“…[3][4][5][6][7][8] Thus far, attempts at measuring embolization during peripheral arterial interventions have been few and with small numbers of patients. [9][10][11] The purpose of this prospective study was to evaluate the incidence of distal embolization during percutaneous SFA intervention using continuous transcutaneous Doppler ultrasound. We quantified the rate of embolization at various phases of intervention, such as during guidewire crossing, balloon angioplasty, stent deployment, and directional atherectomy with either the SilverHawk (FoxHollow Technologies, Redwood City, Calif) device or the Spectranetics excimer laser device (Spectranetics Corporations, Colorado Springs, Colo), and analyzed angiographic and clinical sequelae of these events.…”